We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.81B
AUM Growth
-$531M
Cap. Flow
-$1.24B
Cap. Flow %
-25.85%
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256
Avg Time Held Equity + Options
0.6 quarters
Top 10 Avg Time Held Equity + Options
0.6 quarters
Top 20 Avg Time Held Equity + Options
0.4 quarters
Avg Time Held Equity only
0.6 quarters
Top 10 Avg Time Held Equity only
0.6 quarters
Top 20 Avg Time Held Equity only
0.4 quarters

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$59.4M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$56.3M
3
SPG icon
Simon Property Group
SPG
+$52M
4
TSM icon
TSMC
TSM
+$45.4M
5
M icon
Macy's
M
+$44.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.53%
2 Real Estate 16.41%
3 Consumer Staples 12.46%
4 Financials 6.75%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GM.PRB icon
251
DELISTED
GENERAL MTRS CO JR PFD CONV SER B (DE)
GM.PRB
$1.01M 0.02%
20,000
– –
2013 Q2
1 quarter
DMND
252
DELISTED
DIAMOND FOODS, INC.
DMND
$990K 0.02%
42,000
-3,500
-8% -$75.4K
2013 Q2
1 quarter
RDA
253
DELISTED
RDA MICROELECTRONICS INC SPONSORED ADR
RDA
$923K 0.02%
+60,400
New +$722K
2013 Q3
0 quarters
RRTS
254
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$847K 0.02%
+1,200
New +$858K
2013 Q3
0 quarters
NBIX icon
255
Neurocrine Biosciences
NBIX
$14.5B
$837K 0.02%
+73,900
New +$1.02M
2013 Q3
0 quarters
SEIC icon
256
SEI Investments
SEIC
$12.6B
$828K 0.02%
+26,800
New +$826K
2013 Q3
0 quarters
SQNM
257
DELISTED
SEQUENOM INC NEW
SQNM
$801K 0.02%
300,000
-259,000
-46% -$870K
2013 Q2
1 quarter
RXII
258
DELISTED
GALENA BIOPHARMA INC COM
RXII
$793K 0.02%
+349,400
New +$793K
2013 Q3
0 quarters
ETFC
259
CALL
DELISTED
E*Trade Financial Corporation
ETFC
$783K 0.02%
470,000
-259,100
-36% -$3.86M
2013 Q2
1 quarter
TPR icon
260
Tapestry
TPR
$23.2B
$778K 0.02%
+14,263
New +$785K
2013 Q3
0 quarters
EARN icon
261
Ellington Residential Mortgage REIT
EARN
$128M
$768K 0.02%
50,000
+25,000
+100% +$383K
2013 Q2
1 quarter
HOT
262
CALL
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$759K 0.02%
220,000
+170,000
+340% +$11.3M
2013 Q2
1 quarter
ROST icon
263
CALL
Ross Stores
ROST
$71B
$755K 0.02%
+400,000
New +$13.7M
2013 Q3
0 quarters
RST
264
DELISTED
ROSETTA STONE INC
RST
$730K 0.02%
45,000
-130,000
-74% -$2.08M
2013 Q2
1 quarter
EPC icon
265
Edgewell Personal Care
EPC
$1.28B
$715K 0.01%
+10,582
New +$782K
2013 Q3
0 quarters
CIE
266
DELISTED
Cobalt International Energy, Inc
CIE
$708K 0.01%
1,899
+383
+25% +$155K
2013 Q2
1 quarter
SPDC
267
DELISTED
SPEED COMMERCE, INC COM STK
SPDC
$656K 0.01%
+200,000
New +$644K
2013 Q3
0 quarters
FDO
268
PUT
DELISTED
FAMILY DOLLAR STORES
FDO
$656K 0.01%
+350,000
New +$24.6M
2013 Q3
0 quarters
TLT icon
269
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$46.7B
$591K 0.01%
585,000
+485,000
+485% +$51.4M
2013 Q2
1 quarter
CGRN
270
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$590K 0.01%
+2,500
New +$623K
2013 Q3
0 quarters
KBIO
271
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$565K 0.01%
15,625
+6,953
+80% +$317K
2013 Q2
1 quarter
AGIO icon
272
Agios Pharmaceuticals
AGIO
$1.9B
$559K 0.01%
+20,000
New +$552K
2013 Q3
0 quarters
CX icon
273
Cemex
CX
$13.8B
$559K 0.01%
+58,493
New +$575K
2013 Q3
0 quarters
NSPH
274
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$550K 0.01%
+13,750
New +$686K
2013 Q3
0 quarters
TEX icon
275
Terex
TEX
$5.79B
$521K 0.01%
+15,516
New +$470K
2013 Q3
0 quarters

Similar funds

UBS O'Connor's Q3 2013 Portfolio in Review

As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor withdrew a net $1.24B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 27% a quarter earlier, followed by Real Estate and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.

  • UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
  • UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
  • UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
  • UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
  • UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
  • UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
  • UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.